State Cannabis Companies Rushed To Apply for DEA Registration but DEA Cannot Rewrite Marijuana Federal Register Rules With a Press Statement 
How Braden Business Systems Use Auvik SaaS Management
to Identify, Secure, and Manage SaaS Sprawl About Braden Business Systems & Jon Fitzryk Since 1989, Braden Business Systems has...
Efficient Network Management: A Dive into Auvik Network Management’s Robust Features
In today's fast-paced digital world, efficient and effective network management has become more important than ever. With businesses relying heavily...
State Cannabis Companies Rushed To Apply for DEA Registration but DEA Cannot Rewrite Marijuana Federal Register Rules With a Press Statement
"DEA Told Cannabis Companies Federal Compliance Mattered - Now the Companies That Ignored the Rules Want Fast Entry Into the...
Europe’s Hospital Cyber Risk Has Moved From Data Theft to Care Disruption, Black Book Study Warns Ahead of HIMSS26 Europe
Pre-HIMSS26 Copenhagen survey of 284 European hospital cybersecurity buyers finds 82% report very high or extreme attack concern as demand...
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically significant sustained duration of effect...
ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026
– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed...
Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
The trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS) A numeric improvement...
UPDATE – Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Hikaru Kuribayashi, 17, receives $100,000 Top Award for his creation of a simulation program to understand complex folding at the...
Range Impact Reports 1Q 2026 Financial Results
CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public...
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian...
Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Hikaru Kuribayashi, 17, receives $100,000 Top Award for his creation of a simulation program to understand complex folding at the...
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”)...
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
Nes-Ziona, Israel, May 15, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company...
UberDoc Health Technologies Announces Leadership Transition
Founder Dr. Paula Muto Named Interim CEO as Company Enters Next Growth PhaseBoston, Massachusetts--(Newsfile Corp. - May 15, 2026) -...
Promino Announces Closing of Second Tranche of Private Placement
Burlington, Ontario--(Newsfile Corp. - May 15, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or...
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
VANCOUVER, BC / ACCESS Newswire / May 15, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN: A3EKSZ) ("Onco" or the "Company") is...
Ensysce Biosciences Reports First Quarter 2026 Financial Results
~ IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent...
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading...
Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
Organon to Present New Research on Access and Value at ISPOR 2026
New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolioJERSEY CITY,...
Imperative Care Appoints Jay Martin as Chief Commercial Officer
Seasoned medtech executive Jay Martin to lead commercial organization as Imperative Care scales across stroke and vascular marketsCAMPBELL, Calif.--(BUSINESS WIRE)--Imperative...
Glidewell TV Celebrates One Year of On-Demand Dental Education
Continued Content Expansion Strengthens Streaming Service Dedicated to Dental Education and Practice Growth IRVINE, CA / ACCESS Newswire / May...